journal article·2016-06

Effects of Pamidronate on Dental Enamel Formation Assessed by Light Microscopy, Energy-Dispersive X-Ray Analysis, Scanning Electron Microscopy, and Microhardness Testing

Ana P. Soares, Renan F. do Espírito Santo, Sérgio R. P. Line, Maria das G. F. Pinto, Pablo de M. Santos, Maria Betania P. Toralles, Alexandre R. do Espírito Santo

Microscopy and Microanalysis· Volume 22· Issue 3
Publisher page

Abstract

Abstract The aim of the present work was to investigate birefringence and morphology of the secretory-stage enamel organic extracellular matrix (EOECM), and structural and mechanical properties of mature enamel of upper incisors from adult rats that had been treated with pamidronate disodium (0.5 mg/kg/week for 56 days), using transmitted polarizing and bright-field light microscopies (TPLM and BFLM), energy-dispersive X-ray (EDX) analysis, scanning electron microscopy (SEM) and microhardness testing. BFLM showed no morphological changes of the EOECM in pamidronate and control groups, but TPLM revealed a statistically significant reduction in optical retardation values of birefringence brightness of pamidronate-treated rats when compared with control animals (p<0.01). EDX analysis showed that pamidronate-induced statistically significant decrease in phosphorus’ quantity in outer mature enamel (p<0.01) and an increase in the calcium/phosphorus ratio in that structure (p<0.05). Pamidronate did not induce ultra-structural alterations in mature enamel as revealed by SEM and did not cause a reduction in its microhardness (p>0.05). The present study indicates that pamidronate can affect birefringence of the secretory-stage EOECM, which does not seem to be associated with significant changes in morphological and/or mechanical properties of mature enamel.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone and Dental Protein Studies · Connective tissue disorders research · Bone health and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. 10.1016/S0140-6736(13)61091-010.1016/S0140-6736(13)61091-0 ↗
2. 10.1369/jhc.5A6853.200610.1369/jhc.5A6853.2006 ↗
3. 10.1111/j.1469-8749.2008.03222.x10.1111/j.1469-8749.2008.03222.x ↗
4. 10.1097/bpo.0b013e3180316d0610.1097/bpo.0b013e3180316d06 ↗
5. Bisphosphonate therapy for osteogenesis imperfecta
6. 10.1177/0895937487001002270110.1177/08959374870010022701 ↗
7. 10.1136/bcr-2012-00853610.1136/bcr-2012-008536 ↗
8. 10.1210/jc.2010-063610.1210/jc.2010-0636 ↗
9. 10.1172/JCI11872210.1172/JCI118722 ↗
10. Dental enamel development: Proteinases and their enamel matrix substrates
11. 10.1056/NEJM19981001339140210.1056/NEJM199810013391402 ↗
12. Prospective use of bisphosphonates in osteoporosis
13. 10.1177/0895937489003002240110.1177/08959374890030022401 ↗
14. 10.1111/j.1651-2227.2003.tb00577.x10.1111/j.1651-2227.2003.tb00577.x ↗
15. Summary of the IADR Cariology Research, Craniofacial Biology, and Mineralized Tissue Groups Symposium, Iguaçu Falls, Brazil, June 2012: Gene-environment interactions and epigenetics in oral diseases: enamel formation and its clinical impact on tooth defects, caries, and erosion
16. 10.2330/joralbiosci1965.33.8210.2330/joralbiosci1965.33.82 ↗
17. 10.1016/S0003-9969(00)00009-110.1016/S0003-9969(00)00009-1 ↗
18. 10.1002/ar.109225031210.1002/ar.1092250312 ↗
19. 10.1002/pbc.2268110.1002/pbc.22681 ↗
20. 10.1080/0300820060105917510.1080/03008200601059175 ↗
21. 10.1016/j.bone.2011.04.02210.1016/j.bone.2011.04.022 ↗
22. 10.1016/j.bjoms.2012.05.00810.1016/j.bjoms.2012.05.008 ↗
23. 10.1210/jc.2008-153110.1210/jc.2008-1531 ↗
24. 10.1055/s-2007-97900810.1055/s-2007-979008 ↗
25. 10.3109/0300820090328011510.3109/03008200903280115 ↗
26. The effect of a single dose of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on secretory ameloblasts and enamel formation in rat incisors
27. 10.1111/j.1600-0722.2008.00529.x10.1111/j.1600-0722.2008.00529.x ↗
28. 10.1007/s00774-011-0262-z10.1007/s00774-011-0262-z ↗
29. 10.1111/j.1600-0722.2006.00326.x10.1111/j.1600-0722.2006.00326.x ↗
30. 10.1007/BF0029665810.1007/BF00296658 ↗
31. 10.1515/jpem-2012-001610.1515/jpem-2012-0016 ↗
32. 10.1016/j.bone.2011.01.01410.1016/j.bone.2011.01.014 ↗
33. 10.1007/s00223-010-9366-z10.1007/s00223-010-9366-z ↗
34. 10.1016/S0003-9969(99)00134-X10.1016/S0003-9969(99)00134-X ↗
35. 10.1159/00036588910.1159/000365889 ↗
36. Mineralization disturbances of the developing rat molar induced by mono- and bisphosphonates
37. 10.1007/s11832-012-0383-510.1007/s11832-012-0383-5 ↗
38. 10.1002/jemt.2205910.1002/jemt.22059 ↗
39. Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive pontencies in vitro and in vivo
40. 10.1097/00001813-200203000-0000610.1097/00001813-200203000-00006 ↗
41. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age
42. 10.3109/0300820950901370010.3109/03008209509013700 ↗
43. 10.1016/0003-9969(90)90064-H10.1016/0003-9969(90)90064-H ↗
44. Bisphosphonate therapy for osteogenesis imperfecta
45. The effect of a single dose of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on presecretory ameloblast differentiation in rat incisors
46. 10.1016/S8756-3282(01)00655-X10.1016/S8756-3282(01)00655-X ↗